ClinOption ApS: Financial statements 2023
CVR: 42731323
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
ClinOption ApS (CVR 42731323) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,834,983 and a net result of DKK 508,086. Equity in the 2023 report amounted to DKK 627,486. The solvency ratio was 51.9%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 1,834,983
- Profit/Loss
- DKK 508,086
- Equity
- DKK 627,486
- Total Assets
- DKK 1,209,096
- Employees
- 2
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
ClinOption ApS has published its interim report for the period September 29, 2021 – December 31, 2022.
About ClinOption ApS
ClinOption ApS is a Danish company of the type Anpartsselskab based in Dyssegård, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Tim Dehli Carstensen. The company is owned by Titi14 HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 1,583,668 and a net result of DKK 414,793 compared with DKK 725,678 the year before. Equity in the 2025 report amounted to DKK 557,956.